Literature DB >> 2528170

Angioplasty and stenting of completely occluded iliac arteries.

C R Rees1, J C Palmaz, O Garcia, T Roeren, G M Richter, G Gardiner, D Schwarten, R A Schatz, H D Root, W Rogers.   

Abstract

Percutaneous angioplasty and placement of balloon-expandable intraluminal stents were performed in 12 iliac occlusions in 12 patients. Indications were limb salvage in seven and claudication in five. After successful stenting, ankle-brachial indexes improved by 0.15 or more in 11 of 12 patients (mean increase, 0.40), transstenotic pressure gradients decreased to less than 5 mm Hg (mean, 0.58 mm Hg) in all patients, and improvement in clinical grade was seen in all patients. At follow-up at 1-14 months (median, 6 months), ankle-brachial indexes were stable (mean, 0.95), and clinical grades were unchanged in all patients. Complications occurred in two patients; both experienced distal embolization, and one, who was receiving corticosteroid therapy, also suffered stent thrombosis. Local surgical embolectomy was successful in both patients, and the thrombosed stent was recanalized with urokinase. This early experience suggests that stenting may play an important role in the management of iliac occlusions, especially in poor surgical candidates.

Entities:  

Mesh:

Year:  1989        PMID: 2528170     DOI: 10.1148/172.3.953

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  11 in total

Review 1.  Endovascular surgery for peripheral arterial occlusive disease. A critical review.

Authors:  S S Ahn; D Eton; W S Moore
Journal:  Ann Surg       Date:  1992-07       Impact factor: 12.969

2.  Stent placement in iliac arterial lesions: three years of clinical experience with the Wallstent.

Authors:  D Vorwerk; R W Günther
Journal:  Cardiovasc Intervent Radiol       Date:  1992 Sep-Oct       Impact factor: 2.740

3.  Stenting of the iliac arteries with the Palmaz stent: experience from a multicenter trial.

Authors:  J C Palmaz; J C Laborde; F J Rivera; C E Encarnacion; J D Lutz; J G Moss
Journal:  Cardiovasc Intervent Radiol       Date:  1992 Sep-Oct       Impact factor: 2.740

4.  Primary stent placement for iliac artery chronic total occlusions.

Authors:  Yuka Kondo; Alan Dardik; Akihito Muto; Jun Koizumi; Masayasu Nishibe; Toshiya Nishibe
Journal:  Surg Today       Date:  2010-04-28       Impact factor: 2.549

5.  Stent placement for chronic iliac arterial occlusive disease: the results of 10 years experience in a single institution.

Authors:  Kwang Bo Park; Young Soo Do; Jae Hyung Kim; Yoon Hee Han; Dong Ik Kim; Duk Kyung Kim; Young Wook Kim; Sung Wook Shin; Sung Ki Cho; Sung Wook Choo; Yeon Hyeon Choe; In Wook Choo
Journal:  Korean J Radiol       Date:  2005 Oct-Dec       Impact factor: 3.500

6.  Management of Proximal Iliac Artery Injury during Lumbar Discectomy with Stent Graft.

Authors:  Sung Cheol Jin; Sang Woo Park; Do Sang Cho
Journal:  J Korean Neurosurg Soc       Date:  2012-04-30

7.  Mid-term outcomes following endovascular re-intervention for iliac artery in-stent restenosis.

Authors:  Usman Javed; Christopher R Balwanz; Ehrin J Armstrong; Khung-Keong Yeo; Gagan D Singh; Satinder Singh; David Anderson; Gregory G Westin; William C Pevec; John R Laird
Journal:  Catheter Cardiovasc Interv       Date:  2013-05-25       Impact factor: 2.692

8.  Total occlusion of iliac arteries: results of balloon angioplasty.

Authors:  A K Gupta; K Ravimandalam; V R Rao; S Joseph; M Unni; A S Rao; K S Neelkandhan
Journal:  Cardiovasc Intervent Radiol       Date:  1993 May-Jun       Impact factor: 2.740

9.  Surgical and percutaneous management of contralateral thrombus dislodgement following stent placement and dilatation of iliac artery occlusions: technical note.

Authors:  D Vorwerk; R W Günther; P Keulers; G Wendt
Journal:  Cardiovasc Intervent Radiol       Date:  1991 Mar-Apr       Impact factor: 2.740

Review 10.  Endovascular revascularization for aortoiliac atherosclerotic disease.

Authors:  Vikas Aggarwal; Stephen W Waldo; Ehrin J Armstrong
Journal:  Vasc Health Risk Manag       Date:  2016-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.